Board of Directors

Tony Giordano, Ph.D

Dr. Giordano is a co-founder and President and CEO of TheraVasc. He has held senior management positions at six separate biotechnology companies, including Message, Nucleonics and Alteris, where he has been involved in business planning, licensing, directing research and development efforts, fundraising and financial management. He is a consultant/advisor to three venture funds, a consultant to the Biomedical Research Foundation, and was recently appointed by the Governor of Louisiana to the Innovation Council. Dr Giordano has secured over $6M in federal funding for the Companies he has managed and has 11 issued and a number of pending patent applications. Before beginning his career in biotech, Dr. Giordano was a senior scientist at Abbott Laboratories.

John Huston, MBA

Mr. Huston, Chairman of the Board, is the founder and manager of the Ohio TechAngel Funds, one of North America’s largest angel groups. During his 30-year commercial banking career, Mr. Huston held positions at five banks in five states ranging from Chief Lending/Chief Credit Officer to CEO. Over the last decade he has been an active angel investor, and served as Chairman of the Angel Capital Association, The Angel Capital Education Foundation, and Vice Chairman of the Ohio Venture Capital Authority.

Amol Soin, MD, MBA

Dr. Soin is chairman and founder of The Ohio Pain Clinic – a network of free-standing chronic pain management facilities in southwestern Ohio focused on non opioid based treatments for chronic pain. He brings a wealth of experience in research, development, biotech angel investing, and regulatory matters to TheraVasc. Currently, he is a physician representative to Medicare via the Clinical Advisory Committee for Ohio and Kentucky. Additionally, he has held several key leadership positions in various statewide and national medical societies including President of the Ohio Society of Interventional Pain Physicians, President – Elect of TriState Pain Society and was appointed by Governor Kasich to the Ohio Medical Board in 2012 to a 5 year term. Dr. Soin has authored several papers, textbook chapters, abstracts, and served as a primary investigator for clinical research. He is also the founder and CEO of a biotech angel investment firm and has experience creating viable medical products from bench research. Dr. Soin serves as a Clinical Assistant Professor of Surgery at Wright State University Medical School. He was selected as one of America’s Top Doctors in Pain Management from 2006 – present, and has won multiple awards for research and patient care. He has also won the “Patients Choice Award” and the “Top Doctors and Patient Choice Award” multiple times for his region. Dr. Soin trained at the Cleveland Clinic, and currently he is an active practicing physician who sees patients that suffer from painful peripheral artery disease, diabetic neuropathy, and poor wound healing on a daily basis. He also serves as Chief Medical Officer.

Kyle W.H. Chan, Ph.D

Dr. Chan is currently the Chief Technology Officer and Global Head of Translational Medicine at BioTheryX. Dr. Chan has over 18 years of experience in physical and life sciences that includes both drug discovery and diagnostics, from a start-up diagnostic company (NovaDx) to a top five biopharmaceutical company (Celgene), where he was the Senior Director of Discovery Research.

William S. Kilroy, II. MBA

Mr. Kilroy has served for the past 20 years as the Chairman of the board of Trust Technologies, a manufacturer of components and assembles servicing the Aerospace and Industrial Gas Turbine markets. Mr. Kilroy is also the founder and managing partner of Portal Capital, a life science equity fund. Portal Capital’s portfolio encompasses businesses in medical devise, software and pharmaceuticals. He started his career with the Cleveland office of Price Waterhouse. He is an active member of the Cleveland Chapter of the Young Presidents Organization (YPO). Mr. Kilroy has been involved in private investments and start-up companies for the past 25 years.

Susan Luria

Susan Luria serves as a long-term consultant at the level of a senior operating and business development executive. Her strengths are in the areas of early stage venture formation, business unit development and resource consolidation, the identification and execution of mutually beneficial strategic partnerships and serving as interim executive management for a variety of clients with a heavy emphasis in the healthcare industry and economic development. Her client list includes University Hospitals Health System, BioEnterprise, Team NEO, Cleveland Clinic Innovations and a Chicago based boutique investment bank and restructuring firm. Prior to beginning her consulting practice, Susan worked in the healthcare industry in various capacities managing operations, mergers, acquisitions, expansion activities and divestitures in both venture-financed and publicly traded healthcare service companies. She has held c-suite level executive positions in emerging ventures and had full P&L responsibility for a number of businesses including a $100 MM/600 employee division of a publicly traded healthcare service company. Susan is an active member of North Coast Angel Fund and serves as a close advisor to a number of early stage ventures.

Management